On February 5, 2026, the U.S. Food and Drug Administration announced a meaningful shift in how it approaches “no artificial colors” claims—alongside new approvals that expand the availability of naturally derived color options.
The headline is clear: the FDA is actively facilitating the transition away from petroleum-based synthetic dyes.
What’s less clear is what this means in practice—and how ready most teams actually are to act on it.
This article explains what changed, what didn’t, and how food and beverage teams should be thinking about readiness in 2026.
What the FDA Announced
In its February 2026 press release, the FDA outlined several coordinated actions.
The FDA will exercise enforcement discretion to allow “no artificial colors” claims when FD&C-certified petroleum-based colors are removed—even if other added colors derived from natural sources remain. Previously, such claims were generally limited to products with no added color of any kind. The agency acknowledged that labeling naturally derived colors as “artificial” has been confusing for consumers and restrictive for manufacturers.
The FDA also approved fermented beetroot red as a new color additive and expanded approved uses of spirulina extract. These actions bring the total number of newly approved natural color options under the current administration to six, helping reduce practical barriers to reformulation.
Senior FDA and HHS leadership framed these steps as part of a broader effort to phase out petroleum-based synthetic colors from the U.S. food supply, with progress tracked through public industry pledges.
In short: the FDA is not just tolerating change—it is encouraging it.
What the Announcement Does Not Do
Despite the clear direction, several realities remain:
- The underlying statute has not been rewritten
- Enforcement discretion does not override state laws or private litigation risk
- The FDA has not declared all “no artificial” claims inherently non-misleading
This is why many regulatory teams continue to advise careful, well-documented transitions. Label changes are slow and costly to reverse, and enforcement policies can change.
Why “Natural” Is a System-Level Decision
While regulatory headlines focus on claims, the real complexity of natural color conversion shows up elsewhere.
These challenges rarely appear in isolation. They compound across formulation, processing, and supply—often in ways teams don’t anticipate early.
For most teams, complexity tends to surface in three interconnected areas:
Stability
Natural colors are more sensitive to pH, heat, and light, often requiring adjustments to processing conditions or packaging.
Formulation & Sensory Impact
Natural colors typically require higher usage rates than synthetic dyes, which can affect flavor, texture, and interactions with other ingredients.
Supply, Scale & System Interactions
In beverages and functional products, factors like emulsification, clarity, and ingredient interactions often become limiting sooner than expected.
These tradeoffs are highly product-specific, which is why timelines and risk profiles vary widely across portfolios.
What This Means for Timing
The FDA has set a clear compliance deadline for Red Dye No. 3 in food products (January 2027), while signaling a broader goal to phase out remaining petroleum-based dyes by the end of 2027.
While that may sound like ample runway, natural color conversion timelines vary widely by product. For some systems, reformulation is relatively straightforward. For others—particularly beverages and functional products—stability testing, sourcing, and scale-up can take 12–24 months or longer.
The issue usually isn’t one missed date. It’s finding out late in the process which products actually needed more time all along.
The Shift in the Conversation
The key question in 2026 is no longer whether the industry is moving toward natural colors.
That answer is yes.
The more useful questions now are:
- Where does complexity show up first in our system?
- Which products can transition quickly—and which require longer lead times?
- What assumptions around processing, packaging, or sourcing need to be tested early?
- Are marketing claims aligned with both FDA guidance and broader legal risk?
This is less about urgency and more about readiness.
The FDA’s February 2026 announcement marks a real inflection point. Direction is clear. Support is growing. Options are expanding. But natural color conversion remains a system-level decision—not a simple ingredient swap.
Teams that evaluate readiness now are better positioned to manage regulatory uncertainty, avoid rushed reformulations, and make informed tradeoffs across color, cost, stability, and scale.
Next Step: Assess Readiness
Reading about complexity is one thing. Understanding where it affects your formulation, process, and supply chain is another.
Our short readiness assessment helps teams understand where natural color conversion is most likely to introduce risk—so they can plan timelines, tradeoffs, and claims with confidence.
